메뉴 건너뛰기




Volumn 31, Issue 1, 1999, Pages 49-53

Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

EID: 0033022847     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007119706336     Document Type: Article
Times cited : (12)

References (10)
  • 1
    • 0021843932 scopus 로고
    • Bacillus Calmette-Guerin immunotherapy for bladder cancer
    • Lamm, D. L.: Bacillus Calmette-Guerin immunotherapy for bladder cancer. J. Urol., 134, 40 (1985).
    • (1985) J. Urol. , vol.134 , pp. 40
    • Lamm, D.L.1
  • 2
    • 0021864629 scopus 로고
    • The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ
    • Brosman, S. A.: The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ. J. Urol., 134, 36 (1985).
    • (1985) J. Urol. , vol.134 , pp. 36
    • Brosman, S.A.1
  • 3
    • 0023228973 scopus 로고
    • Toxicity of intravesical BCG and its management in patients with superficial bladder tumours
    • Orihuela, E., Herr, H. W., Pinsky, C. M., Whitmore, W. F.: Toxicity of intravesical BCG and its management in patients with superficial bladder tumours. Cancer, 60, 326 (1987).
    • (1987) Cancer , vol.60 , pp. 326
    • Orihuela, E.1    Herr, H.W.2    Pinsky, C.M.3    Whitmore, W.F.4
  • 4
    • 0022610692 scopus 로고
    • Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer
    • Lamm, D. L., Stogdill, V. D., Stogdill B. J., Crispen, R. G.: Complications of bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J. Urol., 135, 272 (1986).
    • (1986) J. Urol. , vol.135 , pp. 272
    • Lamm, D.L.1    Stogdill, V.D.2    Stogdill, B.J.3    Crispen, R.G.4
  • 5
    • 0025993157 scopus 로고
    • A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration
    • Graziano, D. A., Jacobs, D., Lozano, R. G., Buck, R. L.: A case of granulomatous hepatitis after intravesical bacillus Calmette-Guerin administration. J. Urol., 146, 1118 (1991).
    • (1991) J. Urol. , vol.146 , pp. 1118
    • Graziano, D.A.1    Jacobs, D.2    Lozano, R.G.3    Buck, R.L.4
  • 7
    • 0023253248 scopus 로고
    • Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma
    • Marans, H. Y., Bekirov, H. M.: Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma. J. Urol., 137, 111 (1987).
    • (1987) J. Urol. , vol.137 , pp. 111
    • Marans, H.Y.1    Bekirov, H.M.2
  • 8
    • 0026530274 scopus 로고
    • Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: Successful treatment with steroids
    • Molina, J. M., Rabian, C., Dagay, M. F., Modai, J.: Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: Successful treatment with steroids. J. Urol, 147, 695 (1995).
    • (1995) J. Urol , vol.147 , pp. 695
    • Molina, J.M.1    Rabian, C.2    Dagay, M.F.3    Modai, J.4
  • 9
    • 0027161333 scopus 로고
    • Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma
    • F. A. C. G.
    • Proctor, D. D., Chopra, S., F. A. C. G., Rubenstein, S. C., Jokela, J. A., Uhl, L.: Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Am. J. Gastroenterology, 88, 1112 (1993).
    • (1993) Am. J. Gastroenterology , vol.88 , pp. 1112
    • Proctor, D.D.1    Chopra, S.2    Rubenstein, S.C.3    Jokela, J.A.4    Uhl, L.5
  • 10
    • 0021135959 scopus 로고
    • Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer
    • Morales, A.: Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer. J. Urol., 132, 457 (1984).
    • (1984) J. Urol. , vol.132 , pp. 457
    • Morales, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.